SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-071878
Filing Date
2023-12-20
Accepted
2023-12-20 16:06:20
Documents
3
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_split_and_articles.htm 6-K 27904
2 EX-99.1 vrax-ex99_1.htm EX-99.1 646678
3 GRAPHIC img90071954_0.jpg GRAPHIC 13253
  Complete submission text file 0000950170-23-071878.txt   694112
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 231501387
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)